Oakbrook Investments’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-3,613
Closed -$943K 290
2019
Q4
$943K Sell
3,613
-3,825
-51% -$1.01M 0.19% 135
2019
Q3
$2.02M Sell
7,438
-450
-6% -$125K 0.13% 111
2019
Q2
$2.17M Buy
7,888
+1,000
+15% +$246K 0.13% 113
2019
Q1
$1.54M Sell
6,888
-200
-3% -$41.3K 0.09% 168
2018
Q4
$1.32M Sell
7,088
-830
-10% -$170K 0.09% 168
2018
Q3
$1.98M Buy
7,918
+2,275
+40% +$552K 0.11% 153
2018
Q2
$1.23M Buy
5,643
+1,513
+37% +$312K 0.08% 183
2018
Q1
$790K Buy
4,130
+75
+2% +$13.8K 0.05% 270
2017
Q4
$634K Sell
4,055
-175
-4% -$27.5K 0.04% 310
2017
Q3
$658K Buy
4,230
+900
+27% +$142K 0.04% 289
2017
Q2
$538K Sell
3,330
-220
-6% -$35.7K 0.04% 313
2017
Q1
$549K Sell
3,550
-1,175
-25% -$162K 0.04% 322
2016
Q4
$554K Buy
+4,725
New +$539K 0.04% 330
2015
Q2
Sell
-4,350
Closed -$336K 562
2015
Q1
$336K Buy
+4,350
New +$339K 0.02% 447
2014
Q4
Sell
-4,500
Closed -$265K 566
2014
Q3
$265K Buy
+4,500
New +$285K 0.01% 457

Other funds holding IDXX

Oakbrook Investments's IDXX Position: Q1 2020 in Review

Oakbrook Investments sold out of Idexx Laboratories (IDXX) in Q1 2020, closing a stake of 3,613 shares — an estimated $943K sold.

Oakbrook Investments first reported a position in IDXX in Q3 2014 and held it in 15 quarters. The position peaked at $2.17M in Q2 2019. 748 funds tracked by Wall St. Rank hold IDXX as of Q1 2020.

  • Oakbrook Investments reported no remaining Idexx Laboratories position as of Q1 2020 after selling out during the quarter.
  • Oakbrook Investments sold 3,613 Idexx Laboratories shares in Q1 2020, an estimated $943K.
  • Oakbrook Investments first reported a position in Idexx Laboratories in Q3 2014 and held it in 15 quarters.
  • Oakbrook Investments's Idexx Laboratories position peaked at $2.17M in Q2 2019.
  • 748 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2020.

Based on Oakbrook Investments's 13F filing for Q1 2020, filed 22 Apr 2020.